bioMérieux ConnectionAn educational resource brought to you by bioMérieux, Inc.
An educational resource brought to you by bioMérieux, Inc.
Lefamulin’s mechanism of action has a low inclination for developing resistance. The drug is a member of the pleuromutilin antibiotic class, and it has low propensity for cross resistance with a variety of antibiotic classes such as macrolide and tetracycline.
In August 2019, the CDC released an update on antibiotic use in the United States. The update includes data on antibiotic stewardship programs and resources, from 2018 studies. The CDC is continuously working to improve antibiotic prescribing and use as a part of the Antibiotic Resistance Solutions Initiative.
This year’s AACC meeting included 300 educational opportunities in the form of lectures, plenary sessions, scientific sessions, and roundtable sessions. Lab automation, sepsis, HIV, infectious disease biomarkers, machine learning, artificial intelligence, and data science took center stage at the educational sessions.
In “From Theory to Practice with Faster Diagnostics: It Takes a Team,” Ravina Kullar, PharmD, MPH, FIDSA, will review the burden of antimicrobial resistance and the importance of early targeted antimicrobial therapy.
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...
WASH, which stands for water, sanitation, and hygiene, are basic...